Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Haas

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Journal of the American Society of Nephrology : JASN|November 9, 2014
Isolated endarteritis and kidney transplant survival: a multicenter collaborative studyBanu Sis, Serena M Bagnasco, Lynn D Cornell, et al.
Kidney International|November 13, 2002
Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytesLihua Bao, O Brad Spiller, Patricia L St John, et al.
Journal of the American Society of Nephrology : JASN|September 9, 2008
C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allograftsMark Haas, Dorry L Segev, Lorraine C Racusen, et al.
Journal of the American Society of Nephrology : JASN|March 24, 2022
Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1Sanjeev Sethi, Benjamin Madden, Marta Casal Moura, et al.
Kidney International|August 24, 2024
FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejectionSanjeev Sethi, Benjamin Madden, Marta Casal Moura, et al.
Transplantation|July 21, 2018
A 2018 Reference Guide to the Banff Classification of Renal Allograft PathologyCandice Roufosse, Naomi Simmonds, Marian Clahsen-van Groningen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus modelHideaki Watanabe, Adam J Mamelak, Elliot Weiss, et al.
Kidney International Reports|May 2, 2022
Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney AllograftsStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
The Journal of Clinical Investigation|April 8, 2009
Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cellsLihua Bao, Mark Haas, Jeffrey Pippin, et al.
Kidney International|September 1, 2020
Consensus definitions for glomerular lesions by light and electron microscopy: recommendations from a working group of the Renal Pathology SocietyMark Haas, Surya V Seshan, Laura Barisoni, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Journal of the American Society of Nephrology : JASN|November 9, 2014
Isolated endarteritis and kidney transplant survival: a multicenter collaborative studyBanu Sis, Serena M Bagnasco, Lynn D Cornell, et al.
Kidney International|November 13, 2002
Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytesLihua Bao, O Brad Spiller, Patricia L St John, et al.
Journal of the American Society of Nephrology : JASN|September 9, 2008
C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allograftsMark Haas, Dorry L Segev, Lorraine C Racusen, et al.
Journal of the American Society of Nephrology : JASN|March 24, 2022
Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1Sanjeev Sethi, Benjamin Madden, Marta Casal Moura, et al.
Kidney International|August 24, 2024
FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejectionSanjeev Sethi, Benjamin Madden, Marta Casal Moura, et al.
Transplantation|July 21, 2018
A 2018 Reference Guide to the Banff Classification of Renal Allograft PathologyCandice Roufosse, Naomi Simmonds, Marian Clahsen-van Groningen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus modelHideaki Watanabe, Adam J Mamelak, Elliot Weiss, et al.
Kidney International Reports|May 2, 2022
Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney AllograftsStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
The Journal of Clinical Investigation|April 8, 2009
Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cellsLihua Bao, Mark Haas, Jeffrey Pippin, et al.
Kidney International|September 1, 2020
Consensus definitions for glomerular lesions by light and electron microscopy: recommendations from a working group of the Renal Pathology SocietyMark Haas, Surya V Seshan, Laura Barisoni, et al.
Pageof 21